Drenth H, Zuidema S, Bautmans I, Marinelli L, Kleiner G, Hobbelen H.
Paratonia in Dementia: A Systematic Review. J Alzheimers Dis. 2020;78(4):1615-1637. doi: 10.3233/JAD-200691. PMID: 33185600; PMCID: PMC7836054.

Van Deun B, Van den Noortgate N, Cinthia S, Van Bladel A, Dirk C.
Paratonia in Flemish Nursing Homes: Current State of Practice. American Journal of Alzheimer’s Disease & Other Dementias®. June 2018:205-214. https://doi.org/10.1177/1533317518760594

Drenth H, Zuidema S, U, Krijnen W, P, Bautmans I, van der Schans C, Hobbelen H:
Psychometric Properties of the MyotonPRO in Dementia Patients with Paratonia. Gerontology 2018;64:401-412.

Kleiner-Fisman G, Khoo E, Moncrieffe N, Forbell T, Gryfe P, et al. (2014)
A Randomized, Placebo Controlled Pilot Trial of Botulinum Toxin for Paratonic Rigidity in People with Advanced Cognitive Impairment. PLOS ONE 9(12): e114733.

Hobbelen, J.S., Verhey, F.R., Bor, J.H. et al.
Passive movement therapy in patients with moderate to severe paratonia; study protocol of a randomised clinical trial (ISRCTN43069940). BMC Geriatr 7, 30 (2007).

Hans Drenth, Sytse Zuidema, Ivan Bautmans, Hans Hobbelen,
The role of inflammaging and advanced glycation end products on paratonia in patients with dementia, Experimental Gerontology, Volume 142, 2020, 111125, ISSN 0531-5565,

Drenth H, Zuidema SU, Krijnen WP, Bautmans I, van der Schans C, Hobbelen H.
Advanced Glycation End-Products Are Associated With the Presence and Severity of Paratonia in Early Stage Alzheimer Disease. J Am Med Dir Assoc. 2017 Jul 1;18(7):636.e7-636.e12. https://doi.org/10.1016/j.jamda.2017.04.004 Epub 2017 May 27. PMID: 28558966.

Van Deun B, Hobbelen JS, Cagnie B, Van Eetvelde B, Van Den Noortgate N,
Cambier D.
Reproducible Measurements of Muscle Characteristics Using the MyotonPRO Device: Comparison Between Individuals With and Without Paratonia. J Geriatr Phys Ther. 2016 Dec 21. DOI: 10.1519/JPT.0000000000000119

Marinelli L, Mori L, Pardini M, Beversdorf D, Cocito L, Currà A, Fattapposta F, Ghilardi MF, Abbruzzese G, Trompetto C.
Electromyographic assessment of paratonia. Exp Brain Res. 2017 Mar;235(3):949-956. DOI: 10.1007/s00221-016-4854-7. Epub 2016 Dec 20. PMID: 27999892.

Marinelli L, Trompetto C, Puce L, Monacelli F, Mori L, Serrati C, Fattapposta F, Ghilardi MF, Currà A.
Electromyographic Patterns of Paratonia in Normal Subjects and in Patients with Mild Cognitive Impairment or Alzheimer’s Disease. J Alzheimers Dis. 2022 Apr 11. DOI: 10.3233/JAD-215526. Epub ahead of print. PMID: 35431243.

Hobbelen JH, Tan FE, Verhey FR, Koopmans RT and De Bie RA.
Passive movement therapy in severe paratonia: a multicenter randomized clinical trial. Int Psychogeriatr 2012;24:834-844. DOI: 10.1017/S1041610211002468

Hobbelen JS, Tan FE, Verhey FR, Koopmans RT, de Bie RA.
Prevalence, incidence and risk factors of paratonia in patients with dementia: a one-year follow-up study. Int Psychogeriatr 2011;23(7):1051-1060. DOI: 10.1017/S1041610210002449

Hobbelen JS, Koopmans RT, Verhey FR, Habraken KM, de Bie RA.
Diagnosing paratonia in the demented elderly: reliability and validity of the Paratonia Assessment Instrument (PAI). Int Psychogeriatr 2008, 20(4):840-852.  DOI: 10.1017/S1041610207006424

Hobbelen JS, Koopmans RT, Verhey FR, Van Peppen RP, de Bie RA.
Paratonia: a delphi procedure for consensus definition. J Geriatr Phys Ther 2006, 29(2):50-56. PMID: 16914066

Hobbelen J, de Bie R, van Rossum E.
Effect of passive movement on severity of paratonia: a partially blinded, randomized clinical trial. Nederlands Tijdschrift voor Fysiotherapie 2003, 113(6):132-137.